# Thrombolysis Combined With Edaravone Dexborneol on Hemorrhagic Transformation for Acute Ischemic Stroke

> **NCT05035953** · PHASE2 · UNKNOWN · sponsor: **Huashan Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Stroke, Ischemic

## Interventions

- **DRUG:** Edaravone Dexborneol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05035953
- **Lead sponsor:** Huashan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-13
- **Primary completion:** 2023-09-13
- **Final completion:** 2024-03-13
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05035953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05035953, "Thrombolysis Combined With Edaravone Dexborneol on Hemorrhagic Transformation for Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05035953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*